Individuals with CMT1 usually show signs of
axon degeneration.
For his research project to explore a novel idea in the field of neurodegeneration, defining the molecular cascade that controls
axon degeneration, which is a key early event in glaucoma, Dr. Richard Libby was awarded the 2017 Shaffer Prize from Glaucoma Research Foundation.
This means Ind - Cl not only inhibits inflammation but is capable of reducing
axon degeneration and restoring neuronal function.»
However, the researchers also found that the death spiral can be slowed when this communication is blocked using a laboratory method that could inspire pharmacological therapies to treat pathological
axon degeneration.
Not exact matches
«This is not the first gene identified whose loss protects mammalian
axons from
degeneration,» DiAntonio says.
Three days after injury, these
axons are protected from
degeneration because they are missing Phr1, a gene involved in removing damaged
axons from the body.
«Treating axonal
degeneration could potentially help a lot of patients because there are so many diseases and conditions where
axons are inappropriately lost,» says Aaron DiAntonio, MD, PhD, professor of developmental biology.
Experiments conducted in mice and in human ALS cells reveal that when RIPK1 is out of control, it can spark axonal damage by setting off a chemical chain reaction that culminates in stripping the protective myelin off of
axons and triggering axonal
degeneration — the hallmark of ALS.
But a new study by University of Virginia researchers challenges this idea and suggests that
axons coordinate each other's destruction, thereby contributing to the
degeneration that makes neurological diseases so devastating and permanent.
The new study by researchers at The Neuro shifts the focus to the loss or
degeneration of
axons, the nerve - cell «branches» that receive and distribute neurochemical signals among neurons.
Severing
axons, or axotomy, is a simple way to study the molecular basis of neurodegeneration as it leads to the activation of explosive axonal
degeneration.
What would be immensely helpful is a drug that could minimize the
degeneration of
axons, thus reducing the rate and degree of MS progression.
«This is not the first gene identified whose loss protects mammalian
axons from
degeneration,» DiAntonio said.
Many scientists have examined
axon development and
degeneration in two - dimensional (2D) systems.
«Treating axonal
degeneration could potentially help a lot of patients because there are so many diseases and conditions where
axons are inappropriately lost,» said Aaron DiAntonio, MD, PhD, professor of developmental biology.
Therefore understanding the dysfunctional molecular pathways that cause mDA axonal
degeneration, and targeting these to protect or re-grow mDA
axons, may be a promising therapeutic approach for PD.
Metabolic Vulnerability Disposes Retinal Ganglion Cell
Axons to Dysfunction in a Model of Glaucomatous
Degeneration Baltan, S., Inman DM., Danilov, CA., Morrison, RS., Horner, PJ.
In patients, the peripheral neuropathy is characterized by
degeneration of sensory
axons and is clinically manifested as numbness, pain, and thermohyperesthesia in hands and feet.